伴或不伴年龄相关性白内障及不同分期糖尿病视网膜病变患者房水中视网膜胶质细胞活化生物标志物
研究纳入82例患者,按有无年龄相关性白内障分层,再分为糖尿病、非增殖性糖尿病视网膜病变(NPDR)、增殖性糖尿病视网膜病变(PDR)和对照组,用ELISA检测房水中AQP1、AQP4、Kir4.1和GFAP浓度。结果显示白内障对照组AQP1高于无白内障对照(P<0.05),糖尿病、NPDR和PDR组AQP1也高于对照(P<0.05);NPDR和PDR组AQP4和GFAP显著升高(P<0.05),Kir4.1显著降低(P<0.05),而糖尿病组这些变化未达显著。有无白内障组间AQP4、Kir4.1和GFAP无差异。
要点
- 白内障对照组房水AQP1浓度高于无白内障对照(P<0.05)。
- 糖尿病、NPDR和PDR组房水AQP1均高于对照(P<0.05)。
- NPDR和PDR组房水AQP4和GFAP显著升高、Kir4.1显著降低(P<0.05)。
核心结论
- 房水AQP1升高可能是无糖尿病患者年龄相关性白内障的生物标志物,也可能是无白内障糖尿病患者的视网膜胶质细胞活化生物标志物。
- 房水AQP4、Kir4.1和GFAP水平提示视网膜胶质细胞活化受糖尿病视网膜病变进展影响。
研究设计与样本
- 研究共纳入82例患者,按有无年龄相关性白内障分层,再按有无糖尿病、非增殖性糖尿病视网膜病变(NPDR)、增殖性糖尿病视网膜病变(PDR)及对照分组。
- 采用ELISA法检测房水样本中水通道蛋白1(AQP1)、水通道蛋白4(AQP4)、内向整流钾通道4.1(Kir4.1)和胶质纤维酸性蛋白(GFAP)浓度。
主要发现
- 白内障对照组房水AQP1浓度高于无白内障对照组(P<0.05)。
- 糖尿病组、NPDR组和PDR组房水AQP1浓度均高于对照组(P<0.05)。
- NPDR组和PDR组房水AQP4和GFAP浓度显著升高(P<0.05),而糖尿病组未显著升高。
- NPDR组和PDR组房水Kir4.1浓度显著降低(P<0.05),而糖尿病组的降低未达统计学显著。
- 有无年龄相关性白内障的患者之间AQP4、Kir4.1和GFAP无差异。
关键数值与推荐
- 房水AQP1在白内障对照组高于无白内障对照(P<0.05)。
- 房水AQP1在糖尿病组、NPDR组和PDR组均高于对照组(P<0.05)。
- 房水AQP4和GFAP在NPDR组和PDR组显著升高(P<0.05),糖尿病组未达显著。
- 房水Kir4.1在NPDR组和PDR组显著降低(P<0.05),糖尿病组降低未达显著。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To clarify the expression of biomarkers of retinal glial cell activation in the aqueous humor (AH) of patients with and without age-related cataracts (ARCs) at different stages of diabetic retinopathy (DR). METHODS: Patients were stratified by the presence of ARCs and then grouped by the presence of diabetes mellitus (DM), nonproliferative DR (NPDR), proliferative DR (PDR), and controls. Water channel aquaporin 1 (AQP1), water channel aquaporin 4 (AQP4), inwardly rectifying potassium channel 4.1 (Kir4.1), and glial fibrillary acidic protein (GFAP) were assayed in AH samples by ELISAs. RESULTS: We enrolled 82 patients. The AQP1 concentration was higher in AH from cataract control patients than in control patients without cataracts (P < 0.05). The APQ1 concentration was also higher in patients with DM, NPDR, and PDR than in controls (P < 0.05). The concentrations of AQP4 and GFAP were significantly increased in patients with NPDR and PDR (P < 0.05) but not in patients with DM. Kir4.1 concentration was significantly decreased in patients with NPDR and PDR (P < 0.05), but the decrease in patients with DM did not reach significance. There were no differences in AQP4, Kir4.1, and GFAP between patients with and without ARCs. CONCLUSIONS: Increased AQP1 in AH may be a biomarker for ARCs in patients without diabetes and a biomarker for retinal glial cell activation in patients with diabetes without cataracts. AQP4, Kir4.1, and GFAP levels in AH suggested that retinal glial cell activation was affected by the progression of DR.
引用
- Zhao M, Zhao S, Tang M, et al. Aqueous Humor Biomarkers of Retinal Glial Cell Activation in Patients With or Without Age-Related Cataracts and With Different Stages of Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2022. PMID: 35262732. doi:10.1167/iovs.63.3.8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。